4 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Bonti, Inc., Competitors or Alternatives

Bonti, Inc.,'s top competitors include Revance, Sova and Neuropn.

Unlock 9 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Bonti, Inc.,'s company profile

Fauad Hasan

Co-Founder & CEO

48/100
1 - 25
$47.7M
$100K - 5M
  • $47.7M
    $100K - 5M
  • 1 - 25
    $47.7M
  • $100K - 5M
  • 48/100
  • 1 - 25
  • $47.7M
  • $100K - 5M
View ProfileView
1
Bonti, Inc.,'s Competitor - Revance logo

Mark J. Foley

President & CEO

81/100
500 - 1,000
$1.5B
$100M - 500M
  • $1.5B
    $100M - 500M
  • 500 - 1,000
    $1.5B
  • $100M - 500M
  • 81/100
  • 500 - 1,000
  • $1.5B
  • $100M - 500M
View ProfileView
2
Bonti, Inc.,'s Competitor - Sova logo

Gary W. Pace

Chairman

82/100
25 - 100
- -
$100K - 5M
  • - -
    $100K - 5M
  • 25 - 100
    - -
  • $100K - 5M
  • 82/100
  • 25 - 100
  • - -
  • $100K - 5M
View ProfileView
3
Bonti, Inc.,'s Competitor - Neuropn logo

Ish Khanna

Co-Founder & CEO

81/100
250 - 500
- -
$100K - 5M
  • - -
    $100K - 5M
  • 250 - 500
    - -
  • $100K - 5M
  • 81/100
  • 250 - 500
  • - -
  • $100K - 5M
View ProfileView
4
Bonti, Inc.,'s Competitor - Ipsen logo

David Loew

CEO

97/100
5,500
$546.4M
$4.8B
  • $546.4M
    $4.8B
  • 5,500
    $546.4M
  • $4.8B
  • 97/100
  • 5,500
  • $546.4M
  • $4.8B
View ProfileView
5
Bonti, Inc.,'s Competitor - Regenacy logo

Simon S. Jones

President & CEO

90/100
25 - 100
$39.3M
$100K - 5M
  • $39.3M
    $100K - 5M
  • 25 - 100
    $39.3M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $39.3M
  • $100K - 5M
View ProfileView
Bonti, Inc.,'s top 12 competitors are Revance, Sova, Neuropn, AbbVie, Ipsen, Regenacy, Merz, Nektar Therapeutics, Cellerant, Exelixis, CytomX and Genprex. Together they have raised over 19.6B between their estimated 61.1K employees. Bonti, Inc.,'s revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 5.7B. Bonti, Inc., has 3 employees and is ranked 13th among it's top 10 competitors. The top 10 competitors average 4,702.

Bonti, Inc., VS Revance

Revance is seen as one of Bonti, Inc.,'s biggest rivals. Revance is headquartered in Nashville, Tennessee, and was founded in 1999. Like Bonti, Inc.,, Revance also works within the Biotechnology sector. Revance generates 12,350% the revenue of Bonti, Inc.,.

Bonti, Inc., VS Sova

Sova is seen as one of Bonti, Inc.,'s top competitors. Sova was founded in 2010, and its headquarters is in La Jolla, California. Sova operates in the Biotechnology industry. Sova has 22 more employees than Bonti, Inc.,.

Bonti, Inc., VS Neuropn

Neuropn is one of Bonti, Inc.,'s top rivals. Neuropn is a Private company that was founded in atlanta, Georgia in 2015. Neuropn operates in the Pharmaceuticals industry. Neuropn has 287 more employees vs. Bonti, Inc.,.

Looking for similar companies to Bonti, Inc.,?

Similar Companies

Biotechnology companies in Newport Beach

See 14 companies 
Companies in Newport Beach with employees in 1-25 range

See 502 companies 
Pharmaceuticals & Biotechnology companies in Newport Beach

See 24 companies 
Biotechnology companies in Los Angeles Metropolitan Area

See 672 companies 
Companies in Newport Beach with revenue in $100K-5.0M range

See 1,051 companies 
Pharmaceuticals & Biotechnology companies in Los Angeles Metropolitan Area

See 1,052 companies 
Biotechnology companies in California

See 3,106 companies 
Biotechnology companies with employees in 1-25 range

See 3,321 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,199 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Bonti, Inc., and Bonti, Inc.,'s Competitors

August 17, 2026GlobalNewswire
Aggregated presentation by day and by market...
August 16, 2026Zolmax News
Nektar Therapeutics (NASDAQ:NKTR) said it initiated its global Phase III ZENITH AD program for rezpegaldesleukin, or REZPEG, in moderate-to-severe atop...
August 18, 2026PR Newswire
Since its 2016 launch, hundreds of exceptional students pursuing higher education have received the scholarship Now a renewable award, students may ear...
August 18, 2026PR Newswire
Collaboration Allows Genprex to Accelerate Manufacturing Processes for IND-Enabling Preclinical Studies and Future Clinical Trials AUSTIN, Texas, Aug. ...
August 16, 2026Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $EXEL--EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law...
August 16, 2026Nasdaq
Key PointsNeuroscience is becoming AbbVie's second major growth engine....

Frequently Asked Questions about Bonti, Inc.,

  1. Who are Bonti, Inc.,'s top competitors?

    Bonti, Inc.,'s top 3 competitors are Revance, Sova, Neuropn.

  2. Who is similar to Bonti, Inc.,?

    Revance is the most similar to Bonti, Inc.,. Sova and Neuropn are also similar to Bonti, Inc.,.

  1. Are Bonti, Inc., and Revance competitors?

    Yes, Revance is one of Bonti, Inc.,’s top competitors.